Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayard L Powell

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Expert Review of Anticancer Therapy|September 21, 2011
Arsenic trioxide in acute promyelocytic leukemia: potion not poisonBayard L Powell
Blood|March 16, 2013
Acute promyelocytic leukemia: progress far and wideBayard L Powell
Current Hematologic Malignancy Reports|April 29, 2010
What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?István Molnár, Bayard L Powell
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2010
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemiaAarati Ranganathan, Bayard L Powell
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Diphtheria toxin conjugate therapy of cancerArthur E Frankel, Bayard L Powell, Michael B Lilly
American Journal of Hematology|September 5, 2002
CD5-negative chronic lymphocytic leukemia or monoclonal B-lymphocytosis of undetermined significance?Yi-Kong Keung, David Buss, Mark Pettenati, et al.
Cancer Genetics and Cytogenetics|August 8, 2002
Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemiaYi-Kong Keung, David Buss, Bayard L Powell, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Acute myelocytic leukemia with rare t(2;11)(q31;p13), skin rash, and fever of unknown originYi-Kong Keung, Mary Ann Knovich, Bayard L Powell, et al.
Expert Opinion on Biological Therapy|April 30, 2003
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemiaArthur E Frankel, Donald R Fleming, Bayard L Powell, et al.
Pediatric Blood & Cancer|February 27, 2008
Hyperleukocytosis from arsenic trioxideMichael Levy, Marcia M Wofford, Bayard L Powell, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Expert Review of Anticancer Therapy|September 21, 2011
Arsenic trioxide in acute promyelocytic leukemia: potion not poisonBayard L Powell
Blood|March 16, 2013
Acute promyelocytic leukemia: progress far and wideBayard L Powell
Current Hematologic Malignancy Reports|April 29, 2010
What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?István Molnár, Bayard L Powell
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2010
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemiaAarati Ranganathan, Bayard L Powell
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Diphtheria toxin conjugate therapy of cancerArthur E Frankel, Bayard L Powell, Michael B Lilly
American Journal of Hematology|September 5, 2002
CD5-negative chronic lymphocytic leukemia or monoclonal B-lymphocytosis of undetermined significance?Yi-Kong Keung, David Buss, Mark Pettenati, et al.
Cancer Genetics and Cytogenetics|August 8, 2002
Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemiaYi-Kong Keung, David Buss, Bayard L Powell, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Acute myelocytic leukemia with rare t(2;11)(q31;p13), skin rash, and fever of unknown originYi-Kong Keung, Mary Ann Knovich, Bayard L Powell, et al.
Expert Opinion on Biological Therapy|April 30, 2003
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemiaArthur E Frankel, Donald R Fleming, Bayard L Powell, et al.
Pediatric Blood & Cancer|February 27, 2008
Hyperleukocytosis from arsenic trioxideMichael Levy, Marcia M Wofford, Bayard L Powell, et al.
Pageof 17